Livforsakringsbolaget Skandia Omsesidigt Buys 308 Shares of CME Group Inc. (NASDAQ:CME)

Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 67.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 767 shares of the financial services provider’s stock after purchasing an additional 308 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in CME Group were worth $165,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CME. Geode Capital Management LLC increased its stake in CME Group by 1.6% in the 1st quarter. Geode Capital Management LLC now owns 7,085,300 shares of the financial services provider’s stock worth $1,355,370,000 after acquiring an additional 108,740 shares during the last quarter. Bank of New York Mellon Corp increased its stake in CME Group by 0.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock worth $1,224,597,000 after acquiring an additional 31,354 shares during the last quarter. Morgan Stanley increased its stake in CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after acquiring an additional 1,163,103 shares during the last quarter. FMR LLC increased its stake in CME Group by 1.8% in the 3rd quarter. FMR LLC now owns 4,029,771 shares of the financial services provider’s stock worth $806,841,000 after acquiring an additional 70,588 shares during the last quarter. Finally, Vontobel Asset Management Inc. increased its stake in CME Group by 3.5% in the 1st quarter. Vontobel Asset Management Inc. now owns 3,962,053 shares of the financial services provider’s stock worth $814,270,000 after acquiring an additional 133,897 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Up 0.6 %

NASDAQ CME opened at $209.65 on Friday. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50 day simple moving average of $214.26 and a two-hundred day simple moving average of $211.61. The stock has a market cap of $75.47 billion, a P/E ratio of 23.64, a price-to-earnings-growth ratio of 5.92 and a beta of 0.49.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the business posted $1.92 EPS. The business’s revenue was up 19.2% on a year-over-year basis. On average, analysts forecast that CME Group Inc. will post 9.56 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a $1.15 dividend. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.19%. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is 51.86%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CME shares. Argus increased their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Rosenblatt Securities reiterated a “sell” rating and set a $180.00 price objective on shares of CME Group in a research report on Thursday, January 4th. Morgan Stanley increased their price objective on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Barclays increased their price objective on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research report on Monday, April 8th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $215.70.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.